Charis Eng, MD, PhD, Cleveland Clinic Genomic Medicine Institute (IMAGE)

Cleveland Clinic

Charis Eng, MD, PhD, Cleveland Clinic Genomic Medicine Institute

Caption

In a newly published study, a team of researchers led by Charis Eng, M.D., Ph.D., Chair of Cleveland Clinic's Genomic Medicine Institute, identified a metabolite that may predict whether individuals with PTEN mutations will develop cancer or autism spectrum disorder.

Credit

Cleveland Clinic

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.